Effectiveness of chest pain centre accreditation on the management of acute coronary syndrome: a retrospective study using a national database.


Journal

BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984

Informations de publication

Date de publication:
11 2021
Historique:
received: 14 05 2020
revised: 22 11 2020
accepted: 26 11 2020
pubmed: 15 1 2021
medline: 31 12 2021
entrez: 14 1 2021
Statut: ppublish

Résumé

Large-scale real-world data to evaluate the impact of chest pain centre (CPC) accreditation on acute coronary syndrome (ACS) emergency care in heavy-burden developing countries like China are rare. This study is a retrospective study based on data from the Hospital Quality Monitoring System (HQMS) database. This study included emergency patients admitted with ACS to hospitals that uploaded clinical data continuously to the database from 2013 to 2016. Propensity score matching was used to compare hospitals with and without CPC accreditation during this period. A longitudinal self-contrast comparison design with mixed-effects models was used to compare management of ACS before and after accreditation. A total of 798 008 patients with ACS from 746 hospitals were included in the analysis. After matching admission date, hospital levels and types and adjusting for possible covariates, patients with ACS admitted to accredited CPCs had lower in-hospital mortality (OR=0.70, 95% CI 0.53 to 0.93), shorter length of stay (LOS; adjusted multiplicative effect=0.89, 95% CI 0.84 to 0.94) and more percutaneous coronary intervention (PCI) procedures (OR=3.53, 95% CI 2.20 to 5.66) than patients admitted in hospitals without applying for CPC accreditation. Furthermore, when compared with the 'before accreditation' group only in accredited CPCs, the in-hospital mortality and LOS decreased and the usage of PCI were increased in both 'accreditation' (for in-hospital mortality: OR=0.86, 95% CI 0.79 to 0.93; for LOS: 0.94, 95% CI 0.93 to 0.95; for PCI: OR=1.22, 95% CI 1.18 to 1.26) and 'after accreditation' groups (for in-hospital mortality: OR=0.90, 95% CI 0.84 to 0.97; for LOS: 0.89, 95% CI 0.89 to 0.90; for PCI: OR=1.36, 95% CI 1.33 to 1.39). The significant benefits of decreased in-hospital mortality, reduced LOS and increased PCI usage were also observed for patients with acute myocardial infarction. CPC accreditation is associated with better management and in-hospital clinical outcomes of patients with ACS. CPC establishment and accreditation should be promoted and implemented in countries with high levels of ACS.

Sections du résumé

BACKGROUND
Large-scale real-world data to evaluate the impact of chest pain centre (CPC) accreditation on acute coronary syndrome (ACS) emergency care in heavy-burden developing countries like China are rare.
METHODS
This study is a retrospective study based on data from the Hospital Quality Monitoring System (HQMS) database. This study included emergency patients admitted with ACS to hospitals that uploaded clinical data continuously to the database from 2013 to 2016. Propensity score matching was used to compare hospitals with and without CPC accreditation during this period. A longitudinal self-contrast comparison design with mixed-effects models was used to compare management of ACS before and after accreditation.
RESULTS
A total of 798 008 patients with ACS from 746 hospitals were included in the analysis. After matching admission date, hospital levels and types and adjusting for possible covariates, patients with ACS admitted to accredited CPCs had lower in-hospital mortality (OR=0.70, 95% CI 0.53 to 0.93), shorter length of stay (LOS; adjusted multiplicative effect=0.89, 95% CI 0.84 to 0.94) and more percutaneous coronary intervention (PCI) procedures (OR=3.53, 95% CI 2.20 to 5.66) than patients admitted in hospitals without applying for CPC accreditation. Furthermore, when compared with the 'before accreditation' group only in accredited CPCs, the in-hospital mortality and LOS decreased and the usage of PCI were increased in both 'accreditation' (for in-hospital mortality: OR=0.86, 95% CI 0.79 to 0.93; for LOS: 0.94, 95% CI 0.93 to 0.95; for PCI: OR=1.22, 95% CI 1.18 to 1.26) and 'after accreditation' groups (for in-hospital mortality: OR=0.90, 95% CI 0.84 to 0.97; for LOS: 0.89, 95% CI 0.89 to 0.90; for PCI: OR=1.36, 95% CI 1.33 to 1.39). The significant benefits of decreased in-hospital mortality, reduced LOS and increased PCI usage were also observed for patients with acute myocardial infarction.
CONCLUSIONS
CPC accreditation is associated with better management and in-hospital clinical outcomes of patients with ACS. CPC establishment and accreditation should be promoted and implemented in countries with high levels of ACS.

Identifiants

pubmed: 33443197
pii: bmjqs-2020-011491
doi: 10.1136/bmjqs-2020-011491
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

867-875

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Pengfei Sun (P)

Department of Cardiology, Peking University First Hospital, Beijing, China.

Jianping Li (J)

Department of Cardiology, Peking University First Hospital, Beijing, China.

Weiyi Fang (W)

Department of Cardiology, Shanghai Chest Hospital, Shanghai, China.

Xi Su (X)

Department of Cardiology, Wuhan Asia Heart Hospital, Wuhan, China.

Bo Yu (B)

Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, China.

Yan Wang (Y)

Department of Cardiology, Xiamen Cardiovascular Hospital Xiamen university, Xiamen, Fujian, China.

Chunjie Li (C)

Emergency Department, Tianjin Chest Hospital, Tianjin, China.

Hu Chen (H)

Corporate Ethics Department, Bureau of Medical Administration National Health Commission of the People's Republic of China, Beijing, China.

Xingang Wang (X)

Department of Cardiology, Peking University First Hospital, Beijing, China.

Bin Zhang (B)

Department of Cardiology, Peking University First Hospital, Beijing, China.

Yuxi Li (Y)

Department of Cardiology, Peking University First Hospital, Beijing, China.

Mohetaboer Momin (M)

Department of Cardiology, Peking University First Hospital, Beijing, China.

Ying Shi (Y)

China Standard Medical Information Research Center, Shenzhen, Guangdong, China.

Haibo Wang (H)

Clinical Trial Unit, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China.

Yan Zhang (Y)

Department of Cardiology, Peking University First Hospital, Beijing, China drzhy1108@163.com dcxiang@foxmail.com huoyong@263.net.cn.

Dingcheng Xiang (D)

Department of Cardiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, Guangdong, China drzhy1108@163.com dcxiang@foxmail.com huoyong@263.net.cn.

Yong Huo (Y)

Department of Cardiology, Peking University First Hospital, Beijing, China drzhy1108@163.com dcxiang@foxmail.com huoyong@263.net.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH